biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0dq-01a-11d-a099-09
biospecimen_aliquot__bcr_aliquot_uuid	50da0300-124c-429e-8627-47b8ff640ea5
biospecimen_aliquot__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0dq-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100475511
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2010-10-12
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a099
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	1.82
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	2.10
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0dq-01a-11d
biospecimen_analyte__bcr_analyte_uuid	a8e1cd8e-fc4a-4683-92e5-474e09047f91
biospecimen_analyte__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0dq-01a
biospecimen_analyte__concentration	0.13
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0dq
biospecimen_diagnostic_slides__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0dq-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	5a98747c-52d9-45ad-bc84-934a96f069eb
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0dq
biospecimen_normal_control__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
biospecimen_portion__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0dq-01a-11
biospecimen_portion__bcr_portion_uuid	4aed427e-4ec8-4069-ba22-31028d05c3f6
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0dq-01a
biospecimen_portion__date_of_creation	2010-06-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0dq-01a-11d
biospecimen_protocol__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0dq-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0dq-01a
biospecimen_sample__bcr_sample_uuid	10285a0d-d8cc-4c20-a8a2-8891d9807599
biospecimen_sample__days_to_collection	190
biospecimen_sample__initial_weight	110
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0dq.d644b589-a6ed-4dcc-97d4-751e22ae3a7d.pdf
biospecimen_sample__pathology_report_uuid	d644b589-a6ed-4dcc-97d4-751e22ae3a7d
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0dq-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0dq-01a-01-msa
biospecimen_slide__bcr_slide_uuid	3e981cdd-f9e6-454a-9746-16e29a072b17
biospecimen_slide__image_file_name	tcga-bh-a0dq-01a-01-msa.3e981cdd-f9e6-454a-9746-16e29a072b17.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	3
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	25
biospecimen_slide__percent_tumor_cells	74
biospecimen_slide__percent_tumor_nuclei	75
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0dq
biospecimen_tumor_sample__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
clinical_drug__bcr_drug_barcode	tcga-bh-a0dq-d4541
clinical_drug__bcr_drug_uuid	a7564051-9ff3-4cf9-8103-e8f1ea030475
clinical_drug__bcr_patient_barcode	tcga-bh-a0dq
clinical_drug__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
clinical_drug__form_completion_date	2010-11-17
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	cyclophosphamide
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	204
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	141
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0dq-f4560
clinical_follow_up__bcr_followup_uuid	cdba9234-ac86-44d5-a25d-cdfa2e27f36d
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0dq
clinical_follow_up__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
clinical_follow_up__form_completion_date	2010-11-16
clinical_follow_up__last_contact_days_to	98
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-bh-a0dq
clinical_nte__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
clinical_patient__age_at_diagnosis	42
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right upper inner quadrant|right
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-bh-a0dq
clinical_patient__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
clinical_patient__birth_days_to	-15533
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	1+
clinical_patient__er_positivity_method	h-score 136
clinical_patient__er_positivity_scale_other	h-score
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	60-69%
clinical_patient__first_surgical_procedure_other	segmental mastectomy
clinical_patient__form_completion_date	2010-11-9
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_ihc_score	0
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	98
clinical_patient__lymph_nodes_examined_count	25
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0dq
clinical_patient__pr_positivity_define_method	h-score 140
clinical_patient__pr_positivity_ihc_intensity_score	1+
clinical_patient__pr_positivity_scale_other	h-score
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	70-79%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	other
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-bh-a0dq
clinical_radiation__bcr_patient_uuid	a851ca14-7bbf-455b-a054-ec03979a4247
clinical_radiation__bcr_radiation_barcode	tcga-bh-a0dq-r4559
clinical_radiation__bcr_radiation_uuid	54780f16-c78a-4736-ae8d-0fdf2d5c1d37
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-11-17
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	377
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	329
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6040
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0DQ-01A-11D-A099-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0DQ-01A-11D-A099-09.bed.meta
manually_curated__id	tcga-bh-a0dq-01a-11d-a099-09
manually_curated__md5sum	b920daacd24486e3446faa8311dc825f
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	50da0300-124c-429e-8627-47b8ff640ea5
manually_curated__tumor_tag	brca
